Literature DB >> 31898686

Synchronous benign Brenner's tumor of ovary with leiomyoma and endometrial adenocarcinoma in a postmenopausal female.

Jyotsana Harit Gaur1, Mohammad Jaseem Hassan1, Arifa Anwar Elahi2, Shaan Khetrapal1, Sabina Khan1, Sujata Jetley1.   

Abstract

Brenner tumors of ovary are usually an incidental finding. It is an uncommon tumor which is seen affecting women of fifth to sixth decade. It is classified under transitional cell tumors of ovary, which includes benign, borderline, and malignant Brenner tumors and transitional cell carcinoma. These tumors have been associated with synchronous and metachronous neoplasia, most commonly other ovarian epithelial tumors such as mucinous cystadenoma. Occasionally, these tumors may be associated with endometrial hyperplasia or carcinomas which are due to hormones elaborated by the stromal component of Brenner tumor. The hormone produced is estrogen and less commonly androgens, which alters the estrogen and progesterone levels, causing hyperstimulation of endometrium. We present a case of 50-year-old postmenopausal women who presented with coexisting incidental Brenner tumor with leiomyoma and Endometrial adenocarcinoma. Only few authors have reported similar tumor occurrence in the past.

Entities:  

Keywords:  Brenner tumor; endometrial adenocarcinoma; estrogen; ovarian tumors; synchronous tumor

Mesh:

Year:  2019        PMID: 31898686     DOI: 10.4103/jcrt.JCRT_109_18

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.331


  2 in total

1.  Coexistence of Benign Brenner Tumor with Mucinous Cystadenoma in an Ovarian Mass.

Authors:  Farzaneh Nazari; Zahra Dehghani
Journal:  Iran J Pathol       Date:  2020-07-16

2.  Brenner tumors of the ovary: clinical features and outcomes in a single-center cohort

Authors:  Dilek Yüksel; Ciğdem Kılıç; Caner Çakır; Günsu Kimyon Cömert; Taner Turan; Eylem Ünlübilgin; Nurettin Boran; Fulya Kayıkçıoğlu; Sevgi Koç
Journal:  J Turk Ger Gynecol Assoc       Date:  2022-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.